Test Set Performance Indicators Correlate Well With Clinical Audit

This article originally appeared here.
Share this content:
Test Set Performance Indicators Correlate Well With Clinical Audit
Test Set Performance Indicators Correlate Well With Clinical Audit

FRIDAY, July 31, 2015 (HealthDay News) -- Some performance indicators for mammography test sets are associated with aspects of clinical audit parameters, according to a study published in the August issue of the Journal of Medical Imaging and Radiation Oncology.

BaoLin Pauline Soh, Ph.D., from Singapore General Hospital, and colleagues generated clinical audit data for each of 20 radiologists over a two-year period. The test set comprised 60 mammographic examinations, consisting of 40 normal and 20 cancer cases. Any identifiable cancer was located and levels of confidence were scored from 2 to 5, with 3 and above considered a recall rating. The authors calculated Jackknifing free response operating characteristic (JAFROC) figure-of-merit (FOM), location sensitivity, and specificity for individual readers.

The researchers observed significant correlations for JAFROC FOM with recall rate at first round of screening, rate of small invasive cancers per 10,000 reads, percentage of cancer reads that were not recalled, and sensitivity (all P = 0.002). Significant correlations were seen for location sensitivity with rate of small invasive cancers per 10,000 reads (P = 0.04), rate of ductal carcinoma in situ (DCIS) per 10,000 reads (P = 0.05), detection rate of all invasive cancers and DCIS per 10,000 reads (P = 0.01), percentage of all cancers not recalled (P = 0.009), and sensitivity (P = 0.009). There were no other significant correlations noted.

"Performance indicators from test set demonstrate significant correlations with specific aspects of clinical performance, although caution needs to be exercised when generalizing test set specificity to the clinical situation," the authors write.

One author is employed by Ziltron; Hologic and Sectra facilitated the workshop and provided the equipment necessary for the sessions.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease


More in Home

ASTRO: No Survival Benefit for Adding EBT to Brachytherapy

ASTRO: No Survival Benefit for Adding EBT to ...

Addition of external beam therapy doesn't improve five-year progression-free survival in prostate cancer

ASTRO: Fewer Side Effects With IMRT in Cervical, Endometrial CA

ASTRO: Fewer Side Effects With IMRT in Cervical, ...

Patients in conventional radiotherapy arm had more high-level adverse events than those in IMRT arm

Many Doctors Reluctant to Reveal Mental Health Issues

Many Doctors Reluctant to Reveal Mental Health Issues

Perceived stigma, fear of career repercussions hinder treatment, study suggests

is free, fast, and customized just for you!

Already a member?

Sign In Now »